ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GSK to begin final-stage trials of respiratory syncytial virus vaccine
October 22, 2020GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage trial results. -
Antigen study provides a new approach to vaccine development for RSV
March 14, 2018Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus… -
Arsanis and Adimab Enter Into License Agreement to Target Respiratory Syncytial Virus (RSV) With Mon
February 28, 2017Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies for pre-emptive and post-infection treatment of serious infectious diseases,
Pharma Sources Insight January 2025
